在患有多重疾病的抑郁老年人中,生态瞬间评估的可行性和可接受性
Irina Mindlis1, Thomas L Rodebaugh2, Dimitris Kiosses3
1Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine, New York, NY, USA.
概括
这项研究探讨了使用生态瞬间评估 (EMA) 来了解老年人的抑郁症和多病症. 研究结果显示,EMA对这一群体来说是可行的和可接受的,为个性化治疗铺平了道路.
科学领域:
- 老年学是一门学科.
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
背景情况:
- 患有多种疾病的老年人抑郁症 (OAMM) 由于症状异质而复杂.
- 需要个性化 (图形) 治疗方法,但在OAMM中基本上未被探索.
- 生态瞬间评估 (EMA) 为捕获实时症状数据提供了一个潜在的方法.
研究的目的:
- 检查使用EMA收集有关OAMM抑郁症和多病症症状的数据的可行性和可接受性.
- 为此群体制定量身定制的,独特的治疗方法奠定基础.
主要方法:
- 患有多重疾病的老年抑郁症 (N=23,平均年龄为80.5) 参与了研究.
- 通过EMA进行了14天的每日调查,收集有关抑郁症和多病症症状的数据.
- 可行性和可接受性通过坚持率,磨损率和参与者满意度来评估.
主要成果:
- 在14天的EMA期间观察到高坚持率 (89%) 和低磨损率 (5%).
- 参与者对研究持续时间,负担以及EMA平台的易用性表示高度满意.
- 超过一半 (55%) 认为完成EMA调查有好处.
结论:
- 欧洲医学杂志 (EMA) 是一种可行且可接受的方法,用于评估老年人的抑郁症和多病症症状.
- 这种方法支持OAMM的个性化,特征性干预措施的开发.
- 进一步的研究可以基于这些发现来测试量身定制的治疗策略.
更多相关视频
11:21Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
Published on: July 27, 2018
8.3K
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
801
相关概念视频
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
